ADT
48
2
CINF
60
3
VIX
21
-8
ALL
57
9
SO
46
2
AA
72
3
DE
46
3
ALLE
50
9
AVY
53
6
CF
48
6
BEN
52
2
CVX
28
-12
CMG
50
6
AFL
42
3
AXP
74
3
CHD
34
2
APD
44
9
CI
48
6
CCL
68
8
DG
74
4
ADT
48
2
CINF
60
3
VIX
21
-8
ALL
57
9
SO
46
2
AA
72
3
DE
46
3
ALLE
50
9
AVY
53
6
CF
48
6
BEN
52
2
CVX
28
-12
CMG
50
6
AFL
42
3
AXP
74
3
CHD
34
2
APD
44
9
CI
48
6
CCL
68
8
DG
74
4
Financhill
Back

Builders FirstSource, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Sell
43

BLDR
Builders FirstSource, Inc.

Last Price:
$109.82
Seasonality Move:
9.11%
Buy
87

KYMR
Kymera Therapeutics, Inc.

Last Price:
$87.93
Seasonality Move:
10.35%
Sell
43
Builders FirstSource, Inc. (BLDR) is a Sell

Is Builders FirstSource, Inc. a Buy, Sell or Hold?

  • The current Builders FirstSource, Inc. [BLDR] share price is $109.87. The Score for BLDR is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • BLDR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
87
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $87.81. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

BLDR Stock Price Chart

What is Builders FirstSource, Inc.'s stock price today?

  • The Builders FirstSource, Inc. share price today is $109.87
    The current trend is relatively stagnant and BLDR is experiencing slight selling pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $87.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

BLDR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.79 Sell
Relative Strength Index (14 RSI): 50.26 Buy
Chaikin Money Flow: -408163 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (101.14 - 111.86) Buy
Bollinger Bands (100): (110.85 - 137.31) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.53 Buy
Relative Strength Index (14 RSI): 71.11 Buy
Chaikin Money Flow: -592960 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (59.18 - 78.14) Buy
Bollinger Bands (100): (43.11 - 66.09) Buy

BLDR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 109.94 Sell
20-day SMA: 106.19 Buy
50-day SMA: 114.24 Sell
200-day SMA: 122.44 Sell
8-day EMA: 109.03 Buy
20-day EMA: 108.91 Buy
50-day EMA: 113.41 Sell
200-day EMA: 126.67 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 77.75 Buy
20-day SMA: 70.43 Buy
50-day SMA: 63.87 Buy
200-day SMA: 45.05 Buy
8-day EMA: 80.77 Buy
20-day EMA: 72.92 Buy
50-day EMA: 64.9 Buy
200-day EMA: 50.57 Buy

Builders FirstSource, Inc. Earnings Growth & BLDR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.40 per share, and a decrease next year of $0.59 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.33 per share.

Builders FirstSource, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):